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Background: Recurrent spontaneous abortion (RSA) refers to 2 or more consecutive pregnancy losses, and RSA
with unknown causes is called unexplained recurrent spontaneous abortion (URSA). Tim-3, a subtype of the T-cell
immunoglobulin domain and mucin domain (Tim) protein family, might be an important regulatory molecule that
plays a pivotal role in URSA, which might be triggered mostly by Th1/Th2 immune deviation. To understand the
etiology and pathogenesis of URSA in Han Chinese women, we investigated the association between polymorphisms
of rs10053538 and rs10515746 in the promoter of Tim-3 and the risk of URSA in Han Chinese women.
Methods: One hundred and forty-eight women with RSA resulting in still birth were enrolled in the URSA group. We
performed tests to rule out congenital reproductive system malformation, reproductive system tumor, endocrine
dyscrasia, and chromosome abnormalities. One hundred and fifty-three women with normal pregnancy leading to live
birth were selected at random to comprise the control group. All women included in this study were genetically
unrelated Han Chinese women. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and
allele-specific polymerase chain reaction (AS-PCR) were used to determine polymorphisms of rs10053538 and
rs10515746, respectively, in all subjects. PCR products were chosen at random for sequencing.
Results: No significant statistical difference was found between the distribution frequency of the GT + TT genotype
and T allele on the rs10053538 locus in the URSA group or the control group (10.1% vs. 11.8%, Chi(2) = 0.205, P = 0.651;
5.1% vs. 6.5%, Chi(2) = 0.592, P = 0.441; respectively). Neither was there a significant difference between the distribution
frequency of the GT + TT genotype and T allele on the rs10515746 locus in the groups (6.8% vs. 3.9%, Chi(2)1.201,
P = 0.273; 3.4% vs. 2.0%, Chi(2) = 1.169, P = 0.280; respectively).
Conclusions: The present study suggested that these polymorphisms of rs10053538 or rs10515746 in the Tim-3
promoter may not be associated with URSA in Han Chinese women.
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Recurrent spontaneous abortion (RSA) refers to 2 or
more consecutive pregnancy losses [1]. RSA is pervasive
in clinical pathological pregnancy, but its pathogenesis is
very complicated. Besides chromosome abnormalities,
anatomic abnormality, endocrine dyscrasia, and infection,
the etiology and pathogenesis of 40–60% RSA patients are
not understood. RSA with unclear causes is called unex-
plained recurrent spontaneous abortion (URSA) [2].
From the view of immunology, a normal pregnancy can
be considered a type of successful HLA-haploidentical
allogeneic transplant. In a normal pregnancy, the mother’s
immune tolerance against the father’s alloantigens is very
strong, and the embryo can be comparable to an allograft
of semi-identical HLA [3]. It has been reported that special
Th2-cell − related phenomena occur in the mother in a
normal pregnancy. The Th1 cells are suppressed, and the
Th1-type cytokines (such as IL-2, IFN-γ, and TNF-α) are
present at an extremely low level or may even be absent.
Th2 cells are mainly assigned to mediate humoral immune
response, stimulate B-cells to secrete antibodies, and main-
tain allograft immune tolerance. Th2-type cytokines con-
tribute greatly to a normal pregnancy [4]. A disequilibrium
of the Th1/Th2 balance together with the over-functioning
of Th1-cells leads to susceptibility to pathological preg-
nancy, including abnormal implantation, fetal growth
retardation, fetal growth arrest, and URSA [5,6].
Tim-3, a subtype of the T-cell immunoglobulin domain
and mucin domain (Tim) protein family, which was first
identified in 2001 [7], is selectively expressed on Th1 cells
but not on Th2 cells and can induce the apoptosis of Th1
cells after specific binding with its main ligand galectin-9
[8]. Popovici et al. found that the expression of galectin-9
was much higher in early decidual cells than in non-
pregnant endometrium epithelial cells [9]. Thus,it is likely
that allograft tolerance weakens after the Tim/galectin-9
pathway is blocked, for the dismissal of Th1 cell suppres-
sion and the enhanced function of Th1 cells, including the
upregulated expression of Th1 cytokines and Th1-type
immune response overbalance. Inversely, activating the
Tim-3/galectin-9 pathway would suppress the immune
response of Th1 cells and benefit the immune tolerance of
allografts [5]. Moreover, Tim-3 expressed on natural killer
(NK) cells was found to be elevated when they were acti-
vated, suppressing the NK-dependent immune response
and strengthening immune tolerance [10].
Tim-3 polymorphism has also been shown to change
the interaction between Tim-3 and its ligand, thereby af-
fecting the processes leading to some immune diseases
[11]. Given all these findings, Tim-3 might be an important
regulatory molecule that plays a pivotal role in URSA,
which might be triggered mostly by Th1/Th2 immune
deviation. Whether anomalies in the activation of the
Tim-3/gelatin-9 pathway, for example, change in thestructure of Tim-3/gelatin-9, their abnormal expression,
or mutual interaction lead to URSA, remains unknown.
Tim-3/Tim-3 polymorphisms and their association with
URSA in Han Chinese women have not been studied thus
far. Here, we examined polymorphisms of rs10053538/
rs10515746 loci in the promoter of Tim-3 and their
relevance to URSA in Han Chinese women.
Methods
The protocols of this research were approved by the Ethics
Committee of Taizhou Hospital. Written informed consent
was obtained from all patients engaged in this study at the
start of the research. Because all the researchers of this
study work for Taizhou Hospital, which is located in
Taizhou, Zhejiang, a Han Chinese habitation in China,
all subjects selected were Han Chinese women.
Patients and DNA samples
One hundred and forty-eight women with RSA resulting
in still birth were enrolled from the Obstetrics and
Gynecology Department of Taizhou Hospital to com-
prise the research group. In addition, 153 patients with
normal pregnancy culminating in live birth were selected at
random from the Obstetrics and Gynecology Department
of Taizhou Hospital to form the control group. They had
delivered at least 1 full-term healthy baby without the aid
of assisted reproductive technologies and had not experi-
enced miscarriage or pregnancy complications in the past.
The abortions included both embryonic and anembryonic
losses before 20 weeks of gestational age, which were deter-
mined by ultrasound dating and/or dating based on the last
menstrual period. All subjects had undergone a compre-
hensive examination, including determination of detailed
medical history, physical examination, beta subunit of
human chorionic gonadotropin (BhCG), and transvagi-
nal three-dimensional ultrasonography. They were also
tested for 75 g oral glucose tolerance, thyroid functions,
anti-cardiolipin antibodies (IgG/IgM), lupus anticoagulant,
anti-thrombin III, protein S, and protein C to rule out
glucose intolerance, endocrine dyscrasia, thrombophilia
factors, urogenital tumor, and congenital reproductive sys-
tem malformation. Patients with chromosome abnormalities
were also excluded from the study. All patients included in
this study were genetically unrelated Han Chinese women.
The genomic DNA of white blood cells from every sample
was extracted according to the recommended procedure of
the DNA isolation kit (Generay, SH, China). The extracted
genomic DNA was dissolved in sterile double disstilled
water. The concentrations and A260/A280 ratios of
the DNA solutions were measured using a nucleic acid
spectrometer (Bio-Rad, CA, USA). DNA samples with
A260/280 ratios ranging from 1.7 to 2.0 were chosen
as polymerase chain reaction (PCR) templates and were
preserved at −80°C.
Shen et al. Reproductive Biology and Endocrinology 2013, 11:104 Page 3 of 7
http://www.rbej.com/content/11/1/104rs10515746 genotyping
Allele-specific polymerase chain reaction (AS-PCR) was
used to examine the rs10515746 locus, and 3 primers
were designed according to the flanking sequence
[GenBank: NM_032782]. The primer sequences were
as follows: F1, 5′-GGCTTATGCTGGGAGTTGCT-3′;
F2, 5′-GGCTTATGCTGGGAGTTGCG-3′; and R1,
5′-GGTGTCTGATTGCCAGTGATTC-3′. F1 and R1
were used to amplify T allele fragments, and F2 and R1
were used to amplify G allele fragments; all the amplified
fragments were 499 bp long. Every sample was subjected to
PCR with F1/R1 and F2/R1. The reaction mixture included
10× PCR buffer, 2.5 μL; dNTP (10 mM each), 0.5 μL;
forward primer, 0.25 μL (20 mmol/L); reverse primer,
0.25 μL (20 mmol/L); DNA template, 0.1 μg; and Taq
DNA polymerase, 2 U. The final volume of the mixture
was made up to 25 μL with double distilled water.
Touchdown PCR was used to amplify the target ampli-
cons. The reaction was heated on a Thermo Cycler
(Bio-rad, CA, USA) to 95°C for 2 min, followed by 94°C
for 30 s, annealing temperature is progressively lowered
from 62°C to 54°C by 1°C every 2 cycles, annealing for 30 s
in every cycle, extension for 40 s, followed by 12 additional
cycles at 54°C for 40 s, 28 cycles were conducted totally,
final extension at 72°C for 10 min. The amplified products
were subjected to 1.8% agarose gel electrophoresis, visual-
ized by ethidium bromide (EB) staining, and photographed
by FireReader (UVItec, CB, UK).
rs10053538 genotyping
Primers were designed according to the flanking se-
quence of rs10053538 provided by GenBank [GenBank:
NM_032782]. Sequences of forward and reverse Tim-3
primers were as follows: 5′-ATGGTCATTTGCTGGT-
TATTAGTT-3′ and 5′-ATGTTGGTCAGGCTGTTCTT-
3′. The PCR mix components were as follows: 10× PCR
buffer, 2.5 μL; dNTP (10 mM each), 0.5 μL; forward primer,
0.25 μL (20 mmol/L); reverse primer, 0.25 μL (20 mmol/L);
DNA template, 0.1 μg; and Taq DNA polymerase, 2 U. The
final volume was made up to 25 μL with double distilled
water. The reaction mixture was subjected to PCR in a
thermal cycler (Bio-Rad) under the following conditions:
95°C for 2 min; followed by 35 cycles each of 94°C for 45 s,
59°C for 45 s, 72°C for 1 min; and a final extension step of
72°C for 10 min. Next, 5 μL of the amplified products was
used for 1.5% agarose gel electrophoresis. The PCR prod-
ucts were visualized by ethidium bromide (EB) staining and
photographed by FireReader. DNA digestion conditions
were as follows: PCR products, 1 μg; 10× buffer solution,
2.0 μL; and restriction endonuclease BseLI, 2.5 U. The final
volume was made up to 20 μL with double distilled water.
PCR products were digested for 16 h at 55°C. The digestion
products were subjected to 2.0% agarose gel electrophoresis,
visualized by EB staining, and photographed by FireReader.DNA sequencing
Some of the PCR products were randomly selected and
then purified with a PCR purification kit. The purified
products were sent to GeneCore BioTechnologies Co.
Ltd., Shanghai for DNA sequencing.
Statistical analysis
Statistical analysis was performed using the SPSS 18.0
software package. The weight factors of both the wild-type
homozygote GG and mutant-type homozygote TT were
2, while the weight factor of mutant heterozygote GT was
1. The allele frequencies (constituent ratio) of each group
were calculated. G(T) allele frequency = (weight factor
of homozygote × the number of homozygote GG(TT) +
weight factor of homozygote × the number of heterozygote
GT)/(2 × the number of patients being studied). The χ2 test
was adopted to compare the allele frequencies of each
group. Hardy-Weinberg equilibrium test was adopted
to examine the demographic representation of the research
group and control group. The relative risks were presented
as the odds ratios (OR) and their 95% confidential intervals
(CI). Significance was defined as P < 0.05.
Results
General characteristics
The ages of the URSA patients ranged from 22 to 44 years
old, while the ages of the control subjects ranged from 21
to 40 years old. The mean ages of the research group and
control group were 29.8 ± 4.3 years old and 28.5 ± 4.0 years
old, respectively. There was no statistically significant differ-
ence between the ages of the 2 patient groups (P > 0.05).
The χ2 values of Hardy-Weinberg equilibrium test of
rs10053538/rs10515746 locus in the URSA group were
0.42 (P = 0.52)/0.18 (P = 0.67), while χ2 values of the
control group were 3.18 (P = 0.07)/0.06 (P = 0.80), re-
spectively. These results suggested that the 2 groups in
our study were in Hardy-Weinberg equilibrium and
were demographically representative.
rs10515746
At this locus, G and T alleles were defined as wild-type and
mutant alleles, respectively. After agarose gel electrophor-
esis, the GG genotypes were defined as wild GG homozy-
gotes, TT genotypes as mutant TT homozygotes, and GT
genotypes as GT heterozygotes (Figure 1). In the present
study, 138 URSA patients had the GG genotype, and the
other 10 URSA patients had the GT genotype. However,
147 control subjects had the GG genotype, and the other
6 had the GT genotype. No patient in the URSA group or
the control group had the TT genotype (Figure 2).
rs10053538
At the rs10053538 locus, the genetic polymorphism was
demonstrated as 3 genotypes (GG, GT, and TT). Because
Figure 1 Electrophoretogram of rs10515746 locus in Tim-3 gene. (1) represented 100 bp DNA marker; (2, 5) represented genotype of GT; (3, 4)
represented genotype of GG.
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tion site of BseLI endonuclease, they could be cleaved
into 2 DNA fragments, namely, of 252 bp and 30 bp,
after digestion. Mutation of this locus (from G to T)
disrupts the recognition site of BseLI endonuclease.
Hence, the PCR products of the TT genotype could only
give rise to 1 kind of fragment, i.e., of 282 bp, while the
PCR products of GT genotype could be split into 3
kinds of DNA fragments: 282 bp, 252 bp, and 30 bp.
Unfortunately, due to their low molecular weight, the
30 bp DNA fragments could not be classified by agarose
gel electrophoresis (Figure 3). Here, 133 URSA patients
had the GG genotype, and the other 15 URSA patients
had the GT genotype; meanwhile, in the control group,
135 had the GG genotype, 16 had the GT genotype,
and 2 had the TT genotype (Figure 4).Figure 2 Sequence diagrams of rs10515746 locus in Tim-3 gene. (1) reGenotypes and frequencies
At the rs10053538 locus on Tim-3, the GG and (GT + TT)
genotypes had frequencies of 89.9% and 10.1%, respectively,
in the URSA group. In contrast, 88.2% of the control sub-
jects had the GG genotype, and the other 11.8% had the
(GT +TT) genotype. There was no significant statistical
difference between the 2 groups (χ2 = 0.205, P = 0.651). At
the rs10515746 locus on Tim-3, the genotype frequencies
for GG and (GT + TT) were 93.2% and 6.8%, respectively,
in the URSA group. In the control group, 96.1% of the
subjects had the GG genotype, and the other 3.9% had
the (GT +TT) genotype. There was no significant statis-
tical difference between the different genotype frequencies
in the 2 groups (χ2 = 1.201, P = 0.273). The frequency of
GT + TT on rs10053538/rs10515746 loci in the URSA
group was of not statistically different from that of thepresented G allele; (2, 5) represented T allele (heterozygote).
Figure 3 Electrophoretogram of post-digestion products of rs10053538 locus in Tim-3 gene. (1) represented 100 bp DNA marker; (2, 3, 4,
7, 10) represented genotype of GG; (5) represented genotype of TT, (6) represented genotype of GT.
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(see Table 1). The frequencies of T allele on rs10053538/
rs10515746 loci in the 2 groups were not statistically dif-
ferent either (P = 0.441, OR = 1.310; P= 0.280, OR= 0.572)
(see Table 2).Figure 4 Sequence diagrams of rs10053538 locus in Tim-3 gene. (1) re
(3) represented genotype of GT (heterozygote).Discussion
Tim-3, also known as hepatitis A virus cellular receptor
2 (HAVCR2), is a newly discovered surface molecule on
T cells, with important immune regulatory functions. In
humans, Tim-3 is located on chromosome 5q33.2. Tim-3presented G allele, (2) represented T allele (homozygote),
Table 1 Distribution of Tim-3 genotypes of the studied
population(%)
Genotype URSA Control χ2 P OR 95% CI
(n = 148) (n = 153)
rs10053538
GG 133(89.9) 135(88.2) 0.205 0.651 1.182 0.572-2.443
GT + TT 15 + 0(10.1) 16 + 2(11.8)
rs10515746
GG 138(93.2) 147(96.1) 1.201 0.273 0.563 0.199-1.591
GT + TT 10 + 0(6.8) 6 + 0(3.9)
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domains such as the signal peptide domain, immuno-
globulin V (IgV) structural domain, mucin-like structural
domain, transmembrane zone, and cytomere domain
of phosphorylation site. In the IgV structural domain,
there are 2 antiparallel β fragments and a metal ion lig-
and binding site (MILIBS), which together function as
the ligand-binding site of Tim-3 [12,13].
In this study, rs10053538 and rs1055746 loci of Tim-3
were studied. Statistical data showed that in both healthy
women and URSA patients, the frequencies of mutant-type
homozygote TT on both loci were low. Hence, the data of
mutant-type homozygote TT and mutant-type heterozygote
GT were merged and re-analyzed by χ2 test. However, still,
no significant statistical difference was found between the
distribution frequencies of GT + TT genotype in either
group (Table 1). The distribution frequencies of T allele on
rs10053538/rs10515746 locus of each group were of no
statistical difference either (see Table 2). All these data sug-
gested that the polymorphisms of rs10053538/rs10515746
may not contribute to the URSA in Han Chinese women.
Tim-3 deficiency has been reported to precipitate the
aggravation of diseases in which the Th1-type immune
response prevails, increasing the magnitude of illness
and mortality [14]. Furthermore, the Th1/Th2-type
cytokine balance leans toward a radical overbalance of
Th1-type cytokine in URSA patients [4]. Herein, it can
be postulated that Tim-3/Tim-3 polymorphisms might
be closely related to URSA.Table 2 Distribution of different alleles on rs10053538
and rs10515746 (%)
Alleles URSA Control χ2 P OR 95% CI
(n = 148) (n = 153)
rs10053538
G 281(94.9) 286(93.5) 0.592 0.441 1.310 0.657-2.610
T 15(5.1) 20(6.5)
rs10515746
G 286(96.6) 300(98.0) 1.169 0.280 0.572 0.205-1.594
T 10(3.4) 6(2.0)Meanwhile, researchers found that the distribution
frequencies of +4259 T/G in Tim-3 in patients with
pancreatic cancer or renal cell carcinoma were statisti-
cally different from those of healthy people [15,16].
The distribution frequencies of +4259 T/G in Tim-3 in
rheumatoid arthritis patients have been shown to be
statistically different compared with those of healthy
people both in the Han Chinese and Hui Chinese [17].
According to another report, in Korea, the distribution
frequencies of +4259 T/G in Tim-3 in children with
dermatitis or asthma were not statistically different
from those of healthy children, but this was not so in
Caucasian or Hispanic children [18].
Given these findings, it might be concluded that Tim-3/
Tim-3 polymorphisms and their association with diseases
not only pertain to the inclusion criteria of subjects but also
to ethnic and regional differences.
Despite the current data don’t complying with the pos-
tulation, the polymorphisms of rs10053538/rs10515746
loci in Tim-3 and their relationship with URSA are still
not that clear. This is because of several reasons. First,
this study included as research subjects only Han
Chinese women in Taizhou, a Han Chinese habitation.
Second, not all patients in this study had a precise record
of miscarriage history. The number of miscarriages was
self-reported; therefore, there might have been errors in
the precise number of miscarriages. Third, many studies
have found that Tim-3 plays an important role in certain
immune diseases. Therefore, the polymorphisms in Tim-3
and their association with URSA, such as the relationship
between genotype and phenotype and their function in
the molecular genetic mechanisms of URSA, warrant
further investigation.
Conclusions
The polymorphism of rs10053538/rs10515746 may not
contribute to the URSA in Han Chinese women. However,
investigation of other SNP sites of the Tim-3 gene and
their relationship with susceptibility to URSA might reveal
meaningful associations.
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